Novel sulfonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers-Reference-Cited by-同舟云学术

Novel sulfonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers

Published:2019-01-01 Issue:1 Volume:34 Page:1030-1040
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Soliman Aiten M.¹,Alqahtani Ali S.²³,Ghorab Mostafa M.¹

Affiliation:

1. Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Nasr City, Cairo, Egypt;

2. Medicinal, Aromatic and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;

3. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/14756366.2019.1609469

Reference47 articles.

1. Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

2. Cutting-Edge Apoptosis-Based Therapeutics

3. A New Class of Naphthalimide-Based Antitumor Agents That Inhibit Topoisomerase II and Induce Lysosomal Membrane Permeabilization and Apoptosis

4. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents

5. Apoptosis: Overview and Signal Transduction Pathways

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors;International Journal of Biological Macromolecules;2024-11

2. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

3. Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer;European Journal of Medicinal Chemistry Reports;2024-08

4. A Review of Recent Progress on the Anticancer Activity of Heterocyclic Compounds;SynOpen;2024-08

5. Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers;Bioorganic Chemistry;2024-07